← All stocks

BridgeBio Pharma, Inc.

BBIO Scheduled selling only

CIK 0001743881 #743 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$3.73M

$3.73M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 7 sales

Net

−$3.73M

$0.00 against sales at will

By person

19 insiders · 7 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kumar Neil

Chief Executive Officer

—

$3.73M (7) scheduled

−$3.73M

749,013

0.3832%

$64.15M

−71.1%

VIKING GLOBAL INVESTORS LP entity

10% owner

—

18,555,375

9.49%

$1.59B

−26.1%

KKR Genetic Disorder L.P.

10% owner

—

13,260,971

6.78%

$1.14B

−47.5%

HOMCY CHARLES J

Director

—

919,876

0.4706%

$78.79M

−25.2%

MCCORMICK FRANK

Director

—

690,558

0.3532%

$59.15M

−32.5%

Trimarchi Thomas

President and CFO

—

336,529

0.1721%

$28.82M

−15.0%

Satvat Ali J.

Director

—

169,983

0.0870%

$14.56M

—

Apuli Maricel

Chief Accounting Officer

—

122,687

0.0628%

$10.51M

−2.3%

STEPHENSON BRIAN C

CFO and Treasurer

—

102,464

0.0524%

$8.78M

+20.1%

Lo Andrew

Director

—

68,662

0.0351%

$5.88M

−72.9%

Hassan Fred

Director

—

29,879

0.0153%

$2.56M

+54.8%

Ellis Andrea

Director

—

22,579

0.0116%

$1.93M

+88.2%

DANIELS RONALD J

Director

—

20,981

0.0107%

$1.80M

+101.7%

MOMTAZEE JAMES C

Director

—

19,070

0.0098%

$1.63M

+124.6%

Scott Randal W.

Director

—

11,589

0.0059%

$992.60K

+131.8%

Dachille Douglas A.

Director

—

10,579

0.0054%

$906.09K

—

AGUIAR ERIC

Director

—

10,579

0.0054%

$906.09K

—

Valantine Hannah

Director

—

9,657

0.0049%

$827.12K

+61.5%

Cook Jennifer E.

Director

—

8,383

0.0043%

$718.00K

+17.2%

BridgeBio Pharma, Inc.

By person

Individual transactions

What was left out